NEWTOWN SQUARE, Pa., May 14 /PRNewswire/ -- The Philadelphia area-based probiotics firm Kibow Biotech will be one of only three (3) Pennsylvania companies invited to present at the BIO 2009 Company Forum, http://www.convention.bio.org, in Atlanta, GA on Tuesday, May 19. BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 member companies and institutions worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies.
Dr. Natarajan Ranganathan, Interim CEO and Senior VP (R&D) of Kibow Biotech, stated, "It is indeed an honor to be selected to be part of this forward-looking group of biotech leaders. I will be presenting the technology and accomplishments of Kibow Biotech, which include the recent launch of Kibow Biotics(R), a patented and proprietary probiotic formulation in support of renal health. Our veterinary formulation, for dogs and cats with moderate to severe kidney failure, has been successfully sold on the North American market for the past three years." The veterinary product is called Azodyl(TM) and is marketed by Vetoquinol - USA, Fort Worth, Texas.
Kibow Biotics was made available in the US (http://www.kibow.com) and in Canada (http://www.gelda.com) in April 2009. The product is a dietary supplement and not a drug; it is not intended to be used as a drug or as a substitute for any drug application. The Company encourages referrals from healthcare professionals, even though Kibow Biotics i
|SOURCE Kibow Biotech, Inc.|
Copyright©2009 PR Newswire.
All rights reserved